Global mRNA Platform Market Research Report 2023-2028: Post COVID-19 Vaccines, mRNA's Promise in Cancer Immunotherapy and Personalized Medicine

News provided by

Dec 01, 2023, 12:15 ET

DUBLIN, Dec. 1, 2023 /PRNewswire/ -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's offering.

Global mRNA Platform Market is anticipated to witness an impressive growth to 2028

The mRNA (messenger RNA) platform is a cutting-edge technology in biotechnology and medicine that uses synthetic RNA molecules to convey genetic information and instructions to cells, allowing them to produce specific proteins. This technology has gained significant attention and success, particularly in vaccine development and the treatment of various diseases.

Beyond vaccines, the mRNA platform is used for therapeutic purposes. Researchers are exploring mRNA-based therapies for a wide range of conditions, including cancer, genetic disorders, autoimmune diseases, and allergies. In cancer immunotherapy, for example, mRNA is designed to instruct immune cells to target and attack cancer cells, harnessing the body's immune system to fight the disease.

The COVID-19 pandemic accelerated the adoption of mRNA technology for vaccine development. The success of mRNA vaccines for COVID-19 generated enormous interest and investment in this technology, highlighting its potential in responding to emerging infectious diseases. mRNA technology's versatility allows for the development of vaccines and therapies for a wide range of diseases, including infectious diseases, cancer, genetic disorders, and autoimmune conditions. This adaptability makes it an attractive platform for addressing various medical challenges.

Key Market Drivers

The Global mRNA Platform Market is poised for remarkable growth, driven by significant advancements, emerging applications, and robust growth drivers. This revolutionary technology, which utilizes messenger RNA (mRNA) to develop vaccines, therapies, and treatments, is reshaping the landscape of medicine and healthcare worldwide.

Advancements Propelling the mRNA Platform Market

Lipid Nanoparticle (LNP) Delivery Systems have emerged as a linchpin in efficiently delivering mRNA to cells, revolutionizing the stability, delivery, and efficacy of mRNA vaccines and therapies. These advancements played a pivotal role in the success of COVID-19 mRNA vaccines. Modified mRNA sequences have been developed, enhancing stability and reducing immunogenicity, thereby extending shelf life and making mRNA vaccines more suitable for distribution and storage. Codon optimization, a technique for fine-tuning genetic code, is boosting protein expression, particularly crucial for therapeutic applications.

Synthetic biology techniques like CRISPR-Cas9 are enabling precise mRNA sequence editing and manipulation, opening new possibilities for mRNA-based therapies targeting genetic diseases. Scalable and cost-effective manufacturing processes have been developed to meet surging demand for mRNA-based vaccines and therapies. These improvements enable rapid production during public health emergencies. mRNA stability at various temperature ranges has been enhanced, reducing the need for ultra-low-temperature storage. Next-Generation Sequencing (NGS) facilitates rapid and accurate mRNA sequence analysis, streamlining the design of tailored mRNA-based therapies.

Emerging Applications Paving the Way for Personalized Medicine

Cancer immunotherapy is one of the most promising emerging applications, with mRNA-based cancer vaccines and therapies stimulating the patient's immune system to target and destroy cancer cells. Beyond infectious diseases like COVID-19, researchers are developing mRNA-based vaccines for diseases such as influenza, HIV, Zika virus, and respiratory syncytial virus (RSV). mRNA technology holds promise for treating rare genetic disorders by delivering modified mRNA to correct genetic defects. Regenerative medicine is another exciting avenue, where mRNA guides stem cell differentiation for tissue repair and replacement.

mRNA is increasingly utilized to deliver gene-editing tools such as CRISPR-Cas9, offering hope for treating genetic diseases and correcting mutations. mRNA-based therapies replace or supplement deficient proteins in patients with genetic or acquired protein deficiencies, such as hemophilia. Researchers are investigating mRNA for autoimmune disease treatments, aiming to regulate and control immune responses. Allergen-specific immunotherapy for allergies is being customized using mRNA technology.

The mRNA platform also plays a pivotal role in personalized medicine, tailoring therapies based on an individual's genetic profile, thereby enhancing treatment outcomes.

Pandemic Response and Vaccines Drive Growth

mRNA technology's rapid development of COVID-19 vaccines by companies like Pfizer-BioNTech and Moderna demonstrated its agility and effectiveness. mRNA vaccines proved highly efficacious, accelerating their adoption and global use. Their adaptability to new virus variants is a key advantage, with mRNA vaccines quickly modified to address emerging strains.

The scalability and rapid production capabilities of mRNA vaccines have supported global vaccination efforts, with governments and organizations recognizing mRNA's potential to respond rapidly to future pandemics.

Key Market Challenges: Vaccine Hesitancy and Variants

Vaccine hesitancy and misinformation can hinder mRNA vaccine adoption, jeopardizing efforts to achieve herd immunity and control infectious diseases. Variants of infectious pathogens, such as SARS-CoV-2, pose challenges to vaccine effectiveness. Rapid adaptation of mRNA vaccines to emerging variants is critical but resource-intensive.

Market Trends and Dominance

In 2022, autoimmune diseases dominated the market, driven by mRNA's potential to modulate immune responses. The largest share belonged to therapeutic vaccines, with mRNA's adaptability being leveraged for cancer vaccines and infectious diseases. Self-amplifying mRNA was the prominent mRNA type, thanks to its enhanced protein production. Pharmaceutical companies played a pivotal role in advancing mRNA-based therapies.

Regional Dominance: North America

North America emerged as the leader in the Global mRNA Platform Market. It boasts influential biotechnology and pharmaceutical companies, world-class research institutions, and substantial investment in mRNA technology. Companies like Pfizer, Moderna, and BioNTech played pivotal roles in developing mRNA-based COVID-19 vaccines.

Conclusion

The Global mRNA Platform Market is on an upward trajectory, driven by advancements, emerging applications, and a global response to pandemics. mRNA technology's adaptability, scalability, and potential for personalized medicine have positioned it as a transformative force in healthcare. Challenges like vaccine hesitancy and variants demand attention, but the market's resilience and innovative spirit promise a future where mRNA-based therapies revolutionize patient care.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global mRNA Platform Market.

AstraZeneca PLC
Asuragen, Inc.
Catalent Pharma Solutions
Arcturus Therapeutics, Inc.
BioNTech AG
CRISPR Therapeutics Inc.
AKESOgen, Inc.
baseclick GmbH
Accent Therapeutics Inc.
Accanis Biotech F&E GmbH & Co KG

Report Scope:

mRNA Platform Market, By Indication:

Autoimmune Diseases
Cancer
Personalized Treatment
Single Cancer Focused
Infectious Diseases
Rare Diseases
Respiratory Diseases

mRNA Platform Market, By Usability:

Prophylactic Vaccines
Therapeutic Drugs
Therapeutic Vaccines

mRNA Platform Market, By mRNA Type:

Nucleoside-Modified mRNA
Self-Amplifying mRNA
Unmodified mRNA

mRNA Platform Market, By End-User:

Hospitals & Clinics
Pharmaceutical Companies
Research Organization

Global mRNA Platform Market, By region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

For more information about this report visit https://www.researchandmarkets.com/r/ili062

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets